Virtu Financial LLC Enveric Biosciences, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$8.8 - $16.2 $964,691 - $1.78 Million	-109,624 Reduced 39.69%	166,560 $36,000
Q1 2022 May 17, 2022	BUY	$12.5 - $52.0 $1.69 Million - $7.04 Million	135,474 Added 96.28%	276,184 $91,000
Q4 2021 Feb 17, 2022	BUY	$46.5 - $104.0 $4.01 Million - $8.97 Million	86,253 Added 158.39%	140,710 $131,000
Q3 2021 Nov 12, 2021	BUY	$80.5 - $175.0 $121,877 - $264,950	1,514 Added 2.86%	54,457 $113,000
Q2 2021 Sep 17, 2021	SELL	$95.0 - $156.5 $12.2 Million - $20.1 Million	-128,311 Reduced 70.79%	52,943 $126,000
Q1 2021 May 19, 2021	BUY	$131.5 - $245.0 $22.5 Million - $41.8 Million	170,740 Added 1623.93%	181,254 $556,000
Q4 2020 Feb 24, 2021	BUY	$74.0 - $740.0 $778,036 - $7.78 Million	10,514 New	10,514 $45,000

Ticker ENVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,078,270
Market Cap $1.04M
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.